Ocular Therapeutix Cash Conversion Cycle 2011-2026 | OCUL

Annual Cash Conversion Cycle Ocular Therapeutix

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
174	63.3	-32.5	-110	-60.9	-180	-143	-2.12 K	-2.71 K	-1.6 K	-2.05 K	-4.59 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
174	-4.59 K	-1.11 K

Quarterly Cash Conversion Cycle Ocular Therapeutix

2026-Q1	2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
65.2	-	47.3	89.9	156	-	98.8	5.74	-42.3	-	51.4	-13.4	-92.9	-	-100	-5.96	-36.2	-	-58	-115	-71.2	-	-116	-314	45.9	103	18.5	-24.8	-1.55 K	36.4	-2.14 K	-1.61 K	-3.48 K	42.4	39.4	47.1	45.7	44.6	23.9	-	19.2	40	37.5	51.3	72.9	59.5	210	310	978	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
978	-3.48 K	-167

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	3.11 K	-	5743.5 %	$ 69.7 M	Canada
Coherus BioSciences CHRS	149	$ 1.57	-3.68 %	$ 184 M	USA
Happiness Biotech Group Limited HAPP	-3.12 K	-	1.35 %	$ 17.8 M	China
Amphastar Pharmaceuticals AMPH	205	$ 16.87	-2.49 %	$ 789 M	USA
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
AstraZeneca PLC AZN	-58	-	-	$ 96.9 B	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Arcturus Therapeutics Holdings ARCT	21.2	$ 7.47	-4.6 %	$ 205 M	Israel
Eton Pharmaceuticals ETON	115	$ 30.26	1.0 %	$ 814 M	USA
Exelixis EXEL	-8.32	$ 50.13	-1.9 %	$ 13.6 B	USA
Fortress Biotech FBIO	-74.9	$ 2.41	4.78 %	$ 67.2 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
AbCellera Biologics ABCL	173	$ 4.09	-7.05 %	$ 1.22 B	Canada
Autolus Therapeutics plc AUTL	119	$ 1.63	2.52 %	$ 434 M	Britain
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Celyad Oncology SA CYAD	-55.7 K	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	214	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	47.6	-	-	$ 344 M	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Gilead Sciences GILD	115	$ 129.58	-1.88 %	$ 161 B	USA
Advaxis ADXS	-82.3 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
Applied Genetic Technologies Corporation AGTC	126	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
Enlivex Therapeutics Ltd. ENLV	-193	$ 0.72	-1.58 %	$ 32.9 M	Israel
Esperion Therapeutics ESPR	99.7	$ 3.12	-	$ 649 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA